Detail The Great Stem Cell Dilemma   Oleh:  O'Brien, Jeffrey M. Jenis: Article from Bulletin/Magazine Dalam koleksi: Fortune vol. 166 no. 6 (Oct. 2012), page 126-135. Topik: Stem Cell Research; Ethical Issues; New Medical Paradigm Ketersediaan Perpustakaan Pusat (Semanggi) Nomor Panggil: FF16.48 Non-tandon: 1 (dapat dipinjam: 0) Tandon: tidak ada     Lihat Detail Induk Isi artikel Breakthroughs promise a new era in medicine, and billionaire donors like Eli Broad and Bill Gross are lending support. But not even Andy Grove can figure out how to make the business work. While stem cells have ignited plenty of religious outrage and political grandstanding, behind the headlines the underlying science has been advancing the way science often does -- by turns slowly and dramatically. To be clear, the earliest stem cell therapies are almost certainly years from distribution. But so much progress has been made at venerable research institutions that it now seems possible to honestly discuss the possibility of a new medical paradigm emerging within a generation. Working primarily with rodents in preclinical trials, MDs and Ph.D.s are making the paralyzed walk and the impotent virile. A stem cell therapy for two types of macular degeneration recently restored the vision of two women. Once they were blind. Now they see! Some experts assert that AMD could be eradicated within a decade. Other scientists are heralding a drug-free fix for HIV/AIDS. Various forms of cancer, Parkinson's, diabetes, heart disease, stroke, and ALS have already been eradicated in mice. If such work translates to humans, it will represent the type of platform advancement that comes along in medicine only once in a lifetime or two. The effect on the economy would be substantial. Champions of stem cell research say it would be on the order of the Internet or even the transistor. Opini Anda Klik untuk menuliskan opini Anda tentang koleksi ini! Kembali

Copyright © 2006, 2007 Unika Atma Jaya, all rights reserved